Suppr超能文献

T1/T2 匹配以区分立体定向放射手术后肿瘤生长与辐射效应。

T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.

机构信息

Department of Neurological Surgery and Center for Image-Guided Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

出版信息

Neurosurgery. 2010 Mar;66(3):486-91; discussion 491-2. doi: 10.1227/01.NEU.0000360391.35749.A5.

Abstract

OBJECTIVE

We define magnetic resonance imaging (MRI) and clinical criteria that differentiate radiation effect (RE) from tumor progression after stereotactic radiosurgery (SRS).

METHODS

We correlated postoperative imaging and histopathological data in 68 patients who underwent delayed resection of a brain metastasis after SRS. Surgical resection was required in these patients because of clinical and imaging evidence of lesion progression 0.3 to 27.7 months after SRS. At the time of SRS, the median target volume was 7.1 mL (range, 0.5-26 mL), which increased to 14 mL (range, 1.3-81 mL) at the time of surgery. After initial SRS, routine contrast-enhanced MRI was used to assess tumor response and to detect potential adverse radiation effects. We retrospectively correlated these serial MRIs with the postoperative histopathology to determine if any routine MRI features might differentiate tumor progression from RE.

RESULTS

The median time from SRS to surgical resection was 6.9 months (range, 0.3-27.7 months). A shorter interval from SRS to resection was associated with a higher rate of tumor recurrence (P = .014). A correspondence between the contrast-enhanced volume on T1-weighted images and the low signal-defined lesion margin on T2-weighted images ("T1/T2 match") was associated with tumor progression at histopathology (P < .0001). Lack of a clear and defined lesion margin on T2-weighted images compared to the margin of contrast uptake on T1-weighted images ("T1/T2 mismatch") was significantly associated with a higher rate of RE in pathological specimens (P < .0001). The sensitivity of the T1/T2 mismatch in identifying RE was 83.3%, and the specificity was 91.1%.

CONCLUSIONS

We found that time to progression and T1/T2 mismatch were able to differentiate tumor progression from RE in most patients. When REs are suspected, surgery may not be necessary if patients respond to conservative measures. When tumor progression is suspected, resection or repeat radiosurgery can be effective, depending on the degree of mass effect.

摘要

目的

我们定义了磁共振成像(MRI)和临床标准,以区分立体定向放射外科(SRS)后放射性效应(RE)和肿瘤进展。

方法

我们对 68 例 SRS 后因病灶进展而行延迟性脑转移瘤切除术的患者的术后影像学和组织病理学资料进行了相关性分析。这些患者需要手术切除,因为在 SRS 后 0.3 至 27.7 个月,临床和影像学证据表明病变进展。在 SRS 时,中位靶体积为 7.1mL(范围 0.5-26mL),在手术时增加至 14mL(范围 1.3-81mL)。在初始 SRS 后,常规使用增强 MRI 评估肿瘤反应并检测潜在的放射性不良反应。我们回顾性地将这些连续 MRI 与术后组织病理学相关联,以确定是否存在任何常规 MRI 特征可以区分肿瘤进展与 RE。

结果

SRS 至手术切除的中位时间为 6.9 个月(范围 0.3-27.7 个月)。SRS 至切除的时间间隔越短,肿瘤复发的发生率越高(P=0.014)。T1 加权像上增强容积与 T2 加权像上低信号定义的病灶边缘之间的对应关系(“T1/T2 匹配”)与组织病理学上的肿瘤进展相关(P<0.0001)。与 T1 加权像上的对比摄取边界相比,T2 加权像上的病灶边界不清晰或无明确边界(“T1/T2 不匹配”)与病理标本中 RE 的发生率显著相关(P<0.0001)。T1/T2 不匹配识别 RE 的敏感性为 83.3%,特异性为 91.1%。

结论

我们发现,在大多数患者中,进展时间和 T1/T2 不匹配能够区分肿瘤进展与 RE。当怀疑 RE 时,如果患者对保守治疗有反应,则可能无需手术。当怀疑肿瘤进展时,根据肿块效应的程度,切除或重复放射外科手术可能是有效的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验